Over recent years, several serum biomarkers for AAA progression have been investigated, including D-dimer, matrix metalloproteinases (MMPs), C-reactive protein (CRP), inflammatory cytokines (e.g., IL-6, TNF-α) (1, 7–9). The gene discussed is CRP; the disease is triple-A syndrome.